Whittier Belief Co. of Nevada Inc. decreased its place in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 1.0% through the second quarter, in line with the corporate in its most up-to-date submitting with the Securities and Alternate Fee. The agency owned 208,019 shares of the corporate’s inventory after promoting 2,156 shares through the interval. Johnson & Johnson accounts for about 0.8% of Whittier Belief Co. of Nevada Inc.’s funding portfolio, making the inventory its twenty second largest place. Whittier Belief Co. of Nevada Inc.’s holdings in Johnson & Johnson have been price $30,404,000 on the finish of the newest reporting interval.
A variety of different institutional buyers and hedge funds additionally not too long ago added to or decreased their stakes within the firm. Christopher J. Hasenberg Inc bought a brand new place in shares of Johnson & Johnson within the first quarter price $31,000. MFA Wealth Advisors LLC bought a brand new stake in Johnson & Johnson through the second quarter valued at $43,000. Vermillion & White Wealth Administration Group LLC bought a brand new stake in Johnson & Johnson through the fourth quarter valued at $44,000. Disciplined Fairness Administration Inc. bought a brand new stake in Johnson & Johnson through the fourth quarter valued at $45,000. Lastly, Grayhawk Funding Methods Inc. raised its stake in Johnson & Johnson by 528.6% through the fourth quarter. Grayhawk Funding Methods Inc. now owns 308 shares of the corporate’s inventory valued at $48,000 after buying a further 259 shares within the final quarter. Institutional buyers personal 69.55% of the corporate’s inventory.
Analysts Set New Value Targets
A variety of equities analysis analysts not too long ago issued experiences on the inventory. Royal Financial institution of Canada reaffirmed an “outperform” score and set a $175.00 value goal on shares of Johnson & Johnson in a analysis be aware on Tuesday, July thirtieth. Morgan Stanley boosted their value goal on shares of Johnson & Johnson from $167.00 to $169.00 and gave the corporate an “equal weight” score in a analysis report on Thursday, July 18th. Daiwa Capital Markets reduce shares of Johnson & Johnson from an “outperform” score to a “impartial” score and reduce their value goal for the corporate from $160.00 to $150.00 in a analysis report on Tuesday, July twenty third. Cantor Fitzgerald reiterated an “chubby” score and set a $215.00 value goal on shares of Johnson & Johnson in a analysis report on Monday, August fifth. Lastly, Sanford C. Bernstein boosted their value goal on shares of Johnson & Johnson from $161.00 to $171.00 in a analysis report on Thursday, July 18th. Seven analysis analysts have rated the inventory with a maintain score, six have given a purchase score and one has given a robust purchase score to the corporate. Based mostly on information from MarketBeat.com, the inventory at the moment has a mean score of “Reasonable Purchase” and a mean value goal of $173.21.
Learn Our Newest Inventory Evaluation on Johnson & Johnson
Johnson & Johnson Inventory Up 0.2 %
NYSE:JNJ opened at $164.23 on Friday. Johnson & Johnson has a 1-year low of $143.13 and a 1-year excessive of $165.83. The corporate has a 50-day shifting common of $155.01 and a 200 day shifting common of $153.38. The agency has a market cap of $395.25 billion, a PE ratio of 10.24, a price-to-earnings-growth ratio of two.63 and a beta of 0.52. The corporate has a debt-to-equity ratio of 0.44, a present ratio of 1.07 and a fast ratio of 0.85.
Johnson & Johnson (NYSE:JNJ – Get Free Report) final launched its quarterly earnings information on Wednesday, July seventeenth. The corporate reported $2.82 earnings per share for the quarter, topping analysts’ consensus estimates of $2.71 by $0.11. Johnson & Johnson had a web margin of 46.34% and a return on fairness of 36.60%. The corporate had income of $22.45 billion through the quarter, in comparison with analyst estimates of $22.33 billion. Throughout the identical interval within the prior yr, the agency earned $2.80 earnings per share. The agency’s income for the quarter was up 4.3% in comparison with the identical quarter final yr. As a gaggle, analysis analysts anticipate that Johnson & Johnson will publish 10.07 EPS for the present fiscal yr.
Johnson & Johnson Broadcasts Dividend
The agency additionally not too long ago disclosed a quarterly dividend, which might be paid on Tuesday, September tenth. Traders of report on Tuesday, August twenty seventh might be paid a $1.24 dividend. This represents a $4.96 dividend on an annualized foundation and a yield of three.02%. The ex-dividend date of this dividend is Tuesday, August twenty seventh. Johnson & Johnson’s dividend payout ratio (DPR) is presently 30.92%.
Johnson & Johnson Firm Profile
Johnson & Johnson, along with its subsidiaries, researches, develops, manufactures, and sells varied merchandise within the healthcare area worldwide. The corporate’s Revolutionary Drugs section gives merchandise for varied therapeutic areas, akin to immunology, together with rheumatoid arthritis, psoriatic arthritis, inflammatory bowel illness, and psoriasis; infectious illnesses comprising HIV/AIDS; neuroscience, consisting of temper problems, neurodegenerative problems, and schizophrenia; oncology, akin to prostate most cancers, hematologic malignancies, lung most cancers, and bladder most cancers; cardiovascular and metabolism, together with thrombosis, diabetes, and macular degeneration; and pulmonary hypertension comprising pulmonary arterial hypertension by retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use.
Learn Extra
Obtain Information & Rankings for Johnson & Johnson Day by day – Enter your e mail handle under to obtain a concise every day abstract of the newest information and analysts’ rankings for Johnson & Johnson and associated firms with MarketBeat.com’s FREE every day e mail publication.
